Skip to content
How It Works
Explore
Resources Ask a Question
Who It's For
Patients
Decode results, prep for appointments, weigh options.
Caregivers & advocates
Carry the research load for someone you love.
Providers & clinicians
Resources for patients in your practice.
Log In Ask a Question
PubMed This is a summary of 23 peer-reviewed journal articles Updated
Medical Genetics

The Blueprint of Rare Syndromes: Genetic Causes and Testing

At a Glance

Syndromes combining craniosynostosis, distinct facial features, and short fingers are usually caused by specific genetic mutations. Identifying the exact gene through Whole Exome Sequencing or targeted panels helps predict a child's future health needs and explains inheritance patterns.

Finding a clear medical answer for your child often begins with a look at their DNA. While the physical features you see—the shape of the skull, the unique facial features, or the length of the fingers—provide the clues, the “blueprint” for these features is found in the genes [1][2].

Why Genetics Matter

The combination of craniosynostosis (early skull fusion), dysmorphism (different facial features), and brachydactyly (short fingers) is highly suggestive of a “syndromic” condition. This means the features are likely caused by a single change in a gene that affects several parts of the body at once [1][3]. Identifying the specific gene involved is vital because it can help doctors predict potential future health needs, such as hearing or dental issues, and provide clarity for your family [4][2].

Key Genes Involved

Researchers have identified several specific genes that can cause this combination of features. Each gene acts differently in the body:

  • FGFR Genes (FGFR1, FGFR2, FGFR3): Mutations in this gene family are the most common causes of syndromic craniosynostosis (such as Crouzon, Apert, and Pfeiffer syndromes) and often involve prominent differences in the face, skull, and limbs [5][6].
  • CDC45: Mutations in this gene cause Meier-Gorlin syndrome 7 (MGS7). It often involves skull fusion and fetal growth restriction [2][7].
  • ERF: This gene is linked to a form of craniosynostosis that may appear later in childhood and can sometimes be associated with speech or behavioral challenges [8][9].
  • MAP3K20: Changes here are linked to a syndrome that includes brachydactyly, skull fusion, and sensorineural hearing loss [10].
  • RSPRY1: This gene is associated with Spondyloepimetaphyseal dysplasia (Faden-Alkuraya type), where short stature and skeletal changes are common alongside the skull and finger findings [11][12].
  • IL11RA: Variants in this gene cause CRSDA (Craniosynostosis, Delayed Eruption of Teeth, and Adactyly/Brachydactyly), which can look similar to other syndromes but often includes specific dental anomalies like extra or delayed teeth [13][14].

How These Conditions Are Passed Down

Inheritance patterns tell us how a genetic change was passed from parents to a child. There are two main patterns seen with these genes:

Pattern Description Common Genes
Autosomal Dominant Only one copy of the changed gene (from either parent) is needed to cause the condition. Often, these are de novo (new) changes that happened by chance and were not inherited [5][4]. ERF, FGFR family
Autosomal Recessive A child must inherit two copies of the changed gene—one from each parent. The parents are “carriers” and usually show no symptoms, but have a 25% chance of passing it to future children [15][13]. RSPRY1, IL11RA, CDC45 (MGS7)

The Power of Advanced Testing

Standard chromosomal tests (like a karyotype or microarray) look for large pieces of missing or extra DNA. However, the changes that cause these specific syndromes are often tiny “spelling errors” within a single gene that those older tests will miss [16][17].

To find these errors, doctors use Whole Exome Sequencing (WES). This advanced test “reads” all the protein-coding parts of your child’s DNA [2][18].

  • Trio Sequencing: Doctors often test both parents along with the child (a “trio”) to quickly see if a change is new (de novo) or inherited [4][19].
  • Targeted Panels: In some cases, doctors may start with a “craniosynostosis panel,” which looks only at a specific group of genes known to cause these issues. This can be faster and more cost-effective if your child’s features strongly match a known syndrome [20][21].
  • The Waiting Period: It is important to know that this process is complex. The results from Whole Exome Sequencing can take several weeks or even months to come back [2]. It is entirely normal to feel anxious during this wait; ask your care team about the expected timeline.
  • Reanalysis: If the first test is negative, the data can be re-evaluated every year or two as scientists discover new genes [22][23].

Genetic testing is a powerful tool to move from a “description” of features to a concrete “diagnosis,” helping you and your care team plan for your child’s future with more confidence [18][4].

Back to Home Page

Common questions in this guide

What genetic tests are used to diagnose craniosynostosis syndromes?
Doctors typically use advanced genetic tests like Whole Exome Sequencing (WES) or targeted craniosynostosis gene panels. These tests can read the DNA at a detailed level to find tiny spelling errors that standard chromosomal tests, like a karyotype, often miss.
Should both parents be genetically tested along with the child?
Yes, doctors often recommend trio sequencing, which involves testing both parents alongside the child. This quickly helps medical teams determine if a genetic change was inherited from a carrier parent or if it is a new change that happened by chance.
What does an autosomal recessive inheritance pattern mean?
Autosomal recessive inheritance means a child must inherit two copies of the changed gene, one from each parent, to develop the syndrome. The parents are usually healthy carriers and have a 25 percent chance of passing the condition to future children.
What happens if my child's initial genetic test is negative?
If the first genetic test does not find a cause, your child's genetic data can be re-evaluated every year or two. Because scientists are constantly discovering new genes, a future reanalysis may identify a cause that wasn't known during the initial test.

Questions to Ask Your Doctor

Curated prompts to bring to your next appointment.

  1. 1.Is our child a candidate for Whole Exome Sequencing (WES) or a targeted craniosynostosis gene panel, and which would you recommend first?
  2. 2.If we perform WES, should both parents also be tested (Trio sequencing) to help identify de novo mutations or carrier status?
  3. 3.Do any of our child’s other symptoms—like dental issues or hearing loss—point toward a specific gene like IL11RA or MAP3K20?
  4. 4.If the initial genetic test is negative, how often should the data be reanalyzed as new genes are discovered?
  5. 5.Does my child's genetic result suggest an autosomal dominant or recessive inheritance pattern, and what does that mean for future children?

Questions For You

Tap a prompt to share your answer — we'll use it plus this page's context to start a tailored conversation.

References

References (23)
  1. 1

    Case report: Craniofrontonasal syndrome caused by a novel variant in the EFNB1 gene in a Colombian woman.

    Pachajoa H, Vasquez-Forero DM, Giraldo-Ocampo S

    Frontiers in genetics 2022; (13()):1092301 doi:10.3389/fgene.2022.1092301.

    PMID: 36685875
  2. 2

    Prenatal diagnosis of Meier-Gorlin syndrome 7: a case presentation.

    Li X, Zhang LZ, Yu L, et al.

    BMC pregnancy and childbirth 2021; (21(1)):381 doi:10.1186/s12884-021-03868-5.

    PMID: 34000999
  3. 3

    Genetic Causes of Craniosynostosis: An Update.

    Goos JAC, Mathijssen IMJ

    Molecular syndromology 2019; (10(1-2)):6-23 doi:10.1159/000492266.

    PMID: 30976276
  4. 4

    Genetic analysis of 280 children with unexplained developmental delay or intellectual disability using whole exome sequencing.

    Xu J, Su W, Wang Y, et al.

    BMC pediatrics 2024; (24(1)):766 doi:10.1186/s12887-024-05245-5.

    PMID: 39587513
  5. 5

    Genetic Syndromes Associated with Craniosynostosis.

    Ko JM

    Journal of Korean Neurosurgical Society 2016; (59(3)):187-91 doi:10.3340/jkns.2016.59.3.187.

    PMID: 27226847
  6. 6

    Heterozygous mutations in ERF cause syndromic craniosynostosis with multiple suture involvement.

    Chaudhry A, Sabatini P, Han L, et al.

    American journal of medical genetics. Part A 2015; (167A(11)):2544-7 doi:10.1002/ajmg.a.37218.

    PMID: 26097063
  7. 7

    Pathogenic variants in CDC45 on the remaining allele in patients with a chromosome 22q11.2 deletion result in a novel autosomal recessive condition.

    Unolt M, Kammoun M, Nowakowska B, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2020; (22(2)):326-335 doi:10.1038/s41436-019-0645-4.

    PMID: 31474763
  8. 8

    Dissection of contiguous gene effects for deletions around ERF on chromosome 19.

    Calpena E, McGowan SJ, Blanco Kelly F, et al.

    Human mutation 2021; (42(7)):811-817 doi:10.1002/humu.24213.

    PMID: 33993607
  9. 9

    Craniosynostosis-4 with Heterozygous Mutation in the ERF Gene: A Case Report.

    Ranganathan R, Jampanapalli SR, Barathi D

    International journal of clinical pediatric dentistry 2024; (17(10)):1163-1167 doi:10.5005/jp-journals-10005-2959.

    PMID: 39650298
  10. 10

    Confirmation of the Hotspot Variant in MAP3K20 Responsible for Deafness, Ectodermal Dysplasia, Craniosynostosis, Ectrodactyly, and Skeletal Anomaly Spectrum.

    Taşdelen E, Gönül M, Öztelcan Gündüz B, et al.

    Molecular syndromology 2026; (17(3)):255-263 doi:10.1159/000547411.

    PMID: 41064052
  11. 11

    Further delineation of spondyloepimetaphyseal dysplasia Faden-Alkuraya type: A RSPRY1-associated spondylo-epi-metaphyseal dysplasia with cono-brachydactyly and craniosynostosis.

    Simsek-Kiper PO, Taskiran EZ, Kosukcu C, et al.

    American journal of medical genetics. Part A 2018; (176(9)):2009-2016 doi:10.1002/ajmg.a.40427.

    PMID: 30063090
  12. 12

    Two sisters with RSPRY1-related spondyloepimetaphyseal dysplasia.

    Singh S, Shah H, Dalal A, et al.

    American journal of medical genetics. Part A 2024; (194(8)):e63601 doi:10.1002/ajmg.a.63601.

    PMID: 38562122
  13. 13

    Evolution of the phenotype of craniosynostosis with dental anomalies syndrome and report of IL11RA variant population frequencies in a Crouzon-like autosomal recessive syndrome.

    Korakavi N, Prokop JW, Seaver LH

    American journal of medical genetics. Part A 2019; (179(4)):668-673 doi:10.1002/ajmg.a.61070.

    PMID: 30811827
  14. 14

    The interleukin-11 receptor variant p.W307R results in craniosynostosis in humans.

    Ahmad I, Lokau J, Kespohl B, et al.

    Scientific reports 2023; (13(1)):13479 doi:10.1038/s41598-023-39466-y.

    PMID: 37596289
  15. 15

    Identification of a Recognizable Progressive Skeletal Dysplasia Caused by RSPRY1 Mutations.

    Faden M, AlZahrani F, Mendoza-Londono R, et al.

    American journal of human genetics 2015; (97(4)):608-15.

    PMID: 26365341
  16. 16

    Diagnostic performance of chromosomal microarray and whole exome sequencing in fetal structural anomalies: a single-center retrospective study.

    Özer L, Aktuna S, Ünsal E

    BMC pregnancy and childbirth 2025; (25(1)):1029 doi:10.1186/s12884-025-08167-x.

    PMID: 41053595
  17. 17

    Diagnostic and clinical utility of exome sequencing and chromosomal microarray in children with GDD/iD: a meta-analysis.

    Tengsujaritkul M, Louthrenoo O, Likhitweerawong N, et al.

    Annals of medicine 2026; (58(1)):2609424 doi:10.1080/07853890.2025.2609424.

    PMID: 41472336
  18. 18

    Challenges of genetic diagnosis of inborn errors of metabolism in a major tertiary care center in Lebanon.

    Salman DO, Mahfouz R, Bitar ER, et al.

    Frontiers in genetics 2022; (13()):1029947 doi:10.3389/fgene.2022.1029947.

    PMID: 36468010
  19. 19

    Clinical Utility of Next-Generation Sequencing for Developmental Disorders in the Rehabilitation Department: Experiences from a Single Chinese Center.

    Liu Y, Liu X, Qin D, et al.

    Journal of molecular neuroscience : MN 2021; (71(4)):845-853 doi:10.1007/s12031-020-01707-4.

    PMID: 32959227
  20. 20

    Focused Exome Sequencing Gives a High Diagnostic Yield in the Indian Subcontinent.

    Duraisamy AJ, Liu R, Sureshkumar S, et al.

    The Journal of molecular diagnostics : JMD 2024; (26(6)):510-519 doi:10.1016/j.jmoldx.2024.03.005.

    PMID: 38582400
  21. 21

    A 2020 update on the use of genetic testing for patients with primary immunodeficiency.

    Chinn IK, Orange JS

    Expert review of clinical immunology 2020; (16(9)):897-909 doi:10.1080/1744666X.2020.1814145.

    PMID: 32822560
  22. 22

    Clinical whole-exome sequencing for the diagnosis of rare disorders with congenital anomalies and/or intellectual disability: substantial interest of prospective annual reanalysis.

    Nambot S, Thevenon J, Kuentz P, et al.

    Genetics in medicine : official journal of the American College of Medical Genetics 2018; (20(6)):645-654 doi:10.1038/gim.2017.162.

    PMID: 29095811
  23. 23

    The odyssey of complex neurogenetic disorders: From undetermined to positive.

    Salinas V, Vega P, Marsili L, et al.

    American journal of medical genetics. Part C, Seminars in medical genetics 2020; (184(4)):876-884 doi:10.1002/ajmg.c.31848.

    PMID: 33084218

This page provides educational information on genetic causes and testing for craniosynostosis syndromes. It does not replace professional genetic counseling or medical advice. Always consult your pediatric geneticist regarding your child's specific case and test results.

Get notified when new evidence is published on Craniosynostosis-dysmorphism-brachydactyly syndrome.

We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.